Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (261-270 of 388) with videos related to

Pageof 39
Sort By:
Vaccine|August 14, 2022
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programsLauri E Markowitz, Mélanie Drolet, Rayleen M Lewis, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modelingMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
BMC Medicine|February 10, 2021
Who should be prioritized for COVID-19 vaccination in China? A descriptive studyJuan Yang, Wen Zheng, Huilin Shi, et al.
Plos Medicine|June 30, 2025
The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysisLucy Goodfellow, Simon R Procter, Mihaly Koltai, et al.
Communications Medicine|May 25, 2024
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic useLaurence S J Roope, Liz Morrell, James Buchanan, et al.
Vaccine|June 29, 2021
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysisFrank Sandmann, Mark Jit, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2020
Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic EvaluationFrank Sandmann, Mark Jit, Nick Andrews, et al.
Infectious Diseases of Poverty|October 8, 2015
The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective surveyJuan Yang, Mark Jit, Kathy S Leung, et al.
BMC Medicine|October 17, 2024
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling studyFabienne Krauer, Felix Guenther, Marina Treskova-Schwarzbach, et al.
Wellcome Open Research|March 21, 2022
Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of satellite-based excess mortality data in 2020Mihaly Koltai, Abdihamid Warsame, Farah Bashiir, et al.
Pageof 39

Showing results (261-270 of 388) with videos related to

Sort By:
Pageof 39
Vaccine|August 14, 2022
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programsLauri E Markowitz, Mélanie Drolet, Rayleen M Lewis, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modelingMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
BMC Medicine|February 10, 2021
Who should be prioritized for COVID-19 vaccination in China? A descriptive studyJuan Yang, Wen Zheng, Huilin Shi, et al.
Plos Medicine|June 30, 2025
The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysisLucy Goodfellow, Simon R Procter, Mihaly Koltai, et al.
Communications Medicine|May 25, 2024
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic useLaurence S J Roope, Liz Morrell, James Buchanan, et al.
Vaccine|June 29, 2021
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysisFrank Sandmann, Mark Jit, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2020
Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic EvaluationFrank Sandmann, Mark Jit, Nick Andrews, et al.
Infectious Diseases of Poverty|October 8, 2015
The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective surveyJuan Yang, Mark Jit, Kathy S Leung, et al.
BMC Medicine|October 17, 2024
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling studyFabienne Krauer, Felix Guenther, Marina Treskova-Schwarzbach, et al.
Wellcome Open Research|March 21, 2022
Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of satellite-based excess mortality data in 2020Mihaly Koltai, Abdihamid Warsame, Farah Bashiir, et al.
Pageof 39